These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

606 related items for PubMed ID: 14628083

  • 1. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
    Hermanová M, Lukás Z, Kroupová I, Kleibl Z, Novotný J, Nenutil R, Pazourková M, Brázdil J, Kren L, Díte P.
    Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.
    Biankin AV, Kench JG, Morey AL, Lee CS, Biankin SA, Head DR, Hugh TB, Henshall SM, Sutherland RL.
    Cancer Res; 2001 Dec 15; 61(24):8830-7. PubMed ID: 11751405
    [Abstract] [Full Text] [Related]

  • 3. Amplification and overexpression of HER-2/neu in invasive ductal carcinomas of the pancreas and pancreatic intraepithelial neoplasms and the relationship to the expression of p21(WAF1/CIP1).
    Hermanová M, Lukás Z, Nenutil R, Brázdil J, Kroupová I, Kren L, Pazourková M, Růzicka M, Díte P.
    Neoplasma; 2004 Dec 15; 51(2):77-83. PubMed ID: 15190415
    [Abstract] [Full Text] [Related]

  • 4. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
    Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE.
    Cancer Res; 1994 Jul 01; 54(13):3568-73. PubMed ID: 8012983
    [Abstract] [Full Text] [Related]

  • 5. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis.
    Löhr M, Klöppel G, Maisonneuve P, Lowenfels AB, Lüttges J.
    Neoplasia; 2005 Jan 01; 7(1):17-23. PubMed ID: 15720814
    [Abstract] [Full Text] [Related]

  • 6. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study.
    Agoff SN, Crispin DA, Bronner MP, Dail DH, Hawes SE, Haggitt RC.
    Mod Pathol; 2001 Mar 01; 14(3):139-46. PubMed ID: 11266517
    [Abstract] [Full Text] [Related]

  • 7. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.
    DiGiuseppe JA, Hruban RH, Offerhaus GJ, Clement MJ, van den Berg FM, Cameron JL, van Mansfeld AD.
    Am J Pathol; 1994 May 01; 144(5):889-95. PubMed ID: 8178941
    [Abstract] [Full Text] [Related]

  • 8. Novel p21WAF1/CIP1 mutations in superficial and invasive transitional cell carcinomas.
    Malkowicz SB, Tomaszewski JE, Linnenbach AJ, Cangiano TA, Maruta Y, McGarvey TW.
    Oncogene; 1996 Nov 07; 13(9):1831-7. PubMed ID: 8934528
    [Abstract] [Full Text] [Related]

  • 9. Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity.
    Yasui W, Akama Y, Kuniyasu H, Yokozaki H, Semba S, Shimamoto F, Tahara E.
    J Pathol; 1996 Oct 07; 180(2):122-8. PubMed ID: 8976868
    [Abstract] [Full Text] [Related]

  • 10. K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster.
    Cerny WL, Mangold KA, Scarpelli DG.
    Cancer Res; 1992 Aug 15; 52(16):4507-13. PubMed ID: 1643642
    [Abstract] [Full Text] [Related]

  • 11. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
    Yamada T, Nakamori S, Ohzato H, Oshima S, Aoki T, Higaki N, Sugimoto K, Akagi K, Fujiwara Y, Nishisho I, Sakon M, Gotoh M, Monden M.
    Clin Cancer Res; 1998 Jun 15; 4(6):1527-32. PubMed ID: 9626473
    [Abstract] [Full Text] [Related]

  • 12. p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations.
    Viale G, Pellegrini C, Mazzarol G, Maisonneuve P, Silverman ML, Bosari S.
    J Pathol; 1999 Feb 15; 187(3):302-7. PubMed ID: 10398083
    [Abstract] [Full Text] [Related]

  • 13. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T, Fujita M, Inoue M, Rice JM, Nakajima R, Tanizawa O, Nomura T.
    Cancer Res; 1993 Apr 15; 53(8):1883-8. PubMed ID: 8385572
    [Abstract] [Full Text] [Related]

  • 14. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH, van Mansfeld AD, Offerhaus GJ, van Weering DH, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL.
    Am J Pathol; 1993 Aug 15; 143(2):545-54. PubMed ID: 8342602
    [Abstract] [Full Text] [Related]

  • 15. Analysis of K-ras mutations in pancreatic tissue after fine needle aspirates.
    Pabst B, Arps S, Binmoeller K, Thul R, Walsemann G, Fenner C, Klapdor R.
    Anticancer Res; 1999 Aug 15; 19(4A):2481-3. PubMed ID: 10470178
    [Abstract] [Full Text] [Related]

  • 16. p53-independent expression of p21waf1/cip1 in preinvasive and invasive squamous neoplasms of the uterine cervix.
    Werness BA, Wang HQ, Chance J, Goldstein DJ.
    Mod Pathol; 1997 Jun 15; 10(6):578-84. PubMed ID: 9195575
    [Abstract] [Full Text] [Related]

  • 17. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
    Laghi L, Orbetegli O, Bianchi P, Zerbi A, Di Carlo V, Boland CR, Malesci A.
    Oncogene; 2002 Jun 20; 21(27):4301-6. PubMed ID: 12082617
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis.
    Löhr M, Müller P, Mora J, Brinkmann B, Ostwald C, Farré A, Lluis F, Adam U, Stubbe J, Plath F, Nizze H, Hopt UT, Barten M, Capellá G, Liebe S.
    Gastrointest Endosc; 2001 Jun 20; 53(7):734-43. PubMed ID: 11375580
    [Abstract] [Full Text] [Related]

  • 20. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
    Lüttges J, Schlehe B, Menke MA, Vogel I, Henne-Bruns D, Klöppel G.
    Cancer; 1999 Apr 15; 85(8):1703-10. PubMed ID: 10223563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.